Xinliang Zhou

机构：Hebei Medical University, Fourth Hospital of Hebei Medical University

发表论文 11 篇 · 总被引 65 次 · h-index 3

代表论文

Bifidobacterium breve predicts the efficacy of anti‐PD ‐1 immunotherapy combined with chemotherapy in Chinese NSCLC patients (2022 · Cancer Medicine · 被引 47)
Colorectal leiomyosarcoma with BRCA2 mutation benefit from treatment with olaparib: a case report (2022 · Journal of Gastrointestinal Oncology · 被引 5)
Prognostic effect of TP53 mutation combined with EGFR mutation or KRAS mutation on non-small cell lung cancer. (2022 · Journal of Clinical Oncology · 被引 3)
ALK fusion typing and response to crizotinib in ALK+ lung cancer-naive patients. (2022 · Journal of Clinical Oncology · 被引 3)
Correction: miR-200c inhibits TGF-β-induced-EMT to restore trastuzumab sensitivity by targeting ZEB1 and ZEB2 in gastric cancer (2020 · Cancer Gene Therapy · 被引 3)
The prognosis of EGFR complex mutation or co-mutation with tyrosine kinase inhibitor treatment in non-small cell lung cancer. (2022 · Journal of Clinical Oncology · 被引 2)